The Role of Ga-68 PSMA PET/CT Scan on Differentiating of Oligometastatic and High Risk Prostate Cancer
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.29, sa.3, ss.98-104, 2020 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 29 Sayı: 3
- Basım Tarihi: 2020
- Doi Numarası: 10.4274/mirt.galenos.2020.89421
- Dergi Adı: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.98-104
- Anahtar Kelimeler: Ga-68 PSMA PET/CT, prostate cancer, oligometastasis, SUVmax, THERAPY, BIOLOGY
- Süleyman Demirel Üniversitesi Adresli: Evet
Özet
Objectives: In this study, we aimed to investigate whether Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) scanning is adequate to predict intermediate risk, high risk, or oligometastatic prostate cancer (PCa) as an initial staging modality.